Recombinant Bet v 1 (RP-BV1-1)

Purified from Pichia pastoris culture by HPLC gel filtration. Purity >95 % by silver stained SDS-PAGE

See product insert. 

Preservative-free and carrier-free in phosphate buffered saline, pH 7.4. Steriled filtered.

Glycosylation site N82 mutated (N82Q).

Avoid repeated freeze-thaw cycles

Batard, T. et al: Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy. Int Arch Allergy Immunol 2005, 136 (3), 239-249.

Breiteneder, H.et al: The gene coding for the major birch pollen allergen Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J 1989, 8 (7), 1935-1938.

Spangfort, M. D.et al: Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis. J Immunol 2003, 171 (6), 3084-3090.

Swoboda, I.et al: Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning. J Biol Chem 1995, 270 (6), 2607-2613.

S. Vieths et al.: Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. Reference standards and validation of ELISA methods for their measurement. Pharmeuropa Bio & SN 2012; 118-13.